Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Form 483FOIA Uncovered

United StatesIssued March 13, 2020

View FDA's Record for This Firm

Source: FDA record for this establishment. FDA publishes inspections or enforcement actions for this establishment, listed further down this page, but we have not matched this particular Form 483 to a document or an inspection date FDA has released. It stays out of the default view for that reason.

Observations9

Issue DateMarch 13, 2020

StatusWarning Letter Issued

Related Inspections0

Establishment Details

Firm: Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical
Location: United States
FEI Number: N/A
Issue Date: March 13, 2020
Country: United States

Inspection History

We hold no FDA inspection matched to this establishment.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical FDA Form 483, March 13, 2020